OpenLegislation

Annex

United Kingdom

Original text. Later amendments are not shown.

The purity indicated in this column was the minimum degree of purity of the active substance used for the evaluation made in accordance with Article 89(1) of Regulation (EU) No 528/2012. The active substance in the product placed on the market can be of equal or different purity if it has been proven technically equivalent with the evaluated active substance.

Common NameIUPAC NameIdentification NumbersMinimum degree of purity of the active substancef1 Date of approvalExpiry date of approvalProduct typeSpecific conditions
Didecylmethylpoly(oxyethyl)ammonium propionate

IUPAC Name:

Alpha-[2-(didecylmethylammonio)ethyl]-.omega.-hydroxy-poly(oxy-1,2-ethanediyl) propionate

EC No: None assigned

CAS No: 94667-33-1

86,1 % w/w (dry-weight)1 January 201831 December 20278

The authorisations of biocidal products are subject to the following conditions.

  1. (1)

    The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any use covered by an application for authorisation, but not addressed in the Union level risk assessment of the active substance.

  2. (2)

    In view of the risks identified for the uses assessed, the product assessment shall pay particular attention to:

    1. (a)

      industrial and professional users;

    2. (b)

      groundwater for wood in service that will be exposed to frequent weathering.

  3. (3)

    In view of the risks identified for surface and groundwater, labels and, where provided, safety data sheets of products authorised shall indicate that industrial or professional application shall be conducted within a contained area or on impermeable hard standing with bunding, and that freshly treated timber shall be stored after treatment under shelter or on impermeable hard standing, or both, to prevent direct losses to soil or water, and that any losses from the application of the product shall be collected for reuse or disposal.

Annotations

Footnotes

f1

The purity indicated in this column was the minimum degree of purity of the active substance used for the evaluation made in accordance with Article 89(1) of Regulation (EU) No 528/2012. The active substance in the product placed on the market can be of equal or different purity if it has been proven technically equivalent with the evaluated active substance.